Filomena Perri

Filomena Perri began their work experience as a Pharmacy Trainee at Farmacia Europa Rende in March 2014. Filomena then worked as a QC Analyst at The Janssen Pharmaceutical Companies of Johnson & Johnson from December 2017 to August 2018. After that, they worked at Skillpharma as a Regulatory Affairs Specialist and eCTD Specialist from August 2018 to September 2019. From October 2019 to May 2023, they served as a Ph.D. Student and Graduate Teaching Assistant at Rheinische Friedrich-Wilhelms-Universität Bonn. Currently, they are employed as a Principal Scientist at BioSolveIT, starting from May 2023.

Filomena Perri completed their Ph.D. in Pharmazeutische Chemie at The University of Bonn from 2019 to 2022. Prior to that, they earned a Laurea Magistrale in Chimica e Tecnologia Farmaceutiche (Master's Degree in Pharmaceutical Chemistry and Technology) from the University of Calabria, which they completed in 2017. As a visiting student, Filomena attended the University of Southern California in 2015 to study pharmaceutical chemistry. In 2011, they participated in an Erasmus exchange program at King's College London.

In terms of additional certifications, Filomena obtained a German Language Course A2 certificate from Bonner Graduiertenzentrum in February 2023. Filomena also received the Abilitazione all'esercizio della professione di Farmacista (authorization to practice as a pharmacist) from the Università della Calabria in June 2021. There is no available information about the obtained month and year for their Certificate in Advanced English from the University of Cambridge.